Nanoengineering of vaccines using natural polysaccharides

Currently, there are over 70 licensed vaccines, which prevent the pathogenesis of around 30 viruses and bacteria. Nevertheless, there are still important challenges in this area, which include the development of more active, non-invasive, and thermo-resistant vaccines. Important biotechnological advances have led to safer subunit antigens, such as proteins, peptides, and nucleic acids. However, their limited immunogenicity has demanded potent adjuvants that can strengthen the immune response. Particulate nanocarriers hold a high potential as adjuvants in vaccination. Due to their pathogen-like size and structure, they can enhance immune responses by mimicking the natural infection process. Additionally, they can be tailored for non-invasive mucosal administration (needle-free vaccination), and control the delivery of the associated antigens to a specific location and for prolonged times, opening room for single-dose vaccination. Moreover, they allow co-association of immunostimulatory molecules to improve the overall adjuvant capacity. The natural and ubiquitous character of polysaccharides, together with their intrinsic immunomodulating properties, their biocompatibility, and biodegradability, justify their interest in the engineering of nanovaccines. In this review, we aim to provide a state-of-the-art overview regarding the application of nanotechnology in vaccine delivery, with a focus on the most recent advances in the development and application of polysaccharide-based antigen nanocarriers.

• Publication year

  2015

• Venue

  Biotechnology Advances

• Publication date

  2015-06-03

• Fields of study

  Biology, Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1016/j.biotechadv.2015.05.010PMID 26049133PMCID 7127432
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Medical Applications of Dextran and Its Derivatives

  2017cited by this paper
• Biodistribution and lymph node retention of polysaccharide-based immunostimulating nanocapsules.

  2014cited by this paper
• Oral mucosal immunization using glucomannosylated bilosomes.

  2014cited by this paper
• Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration.

  2014cited by this paper
• Biomaterials for Nanoparticle Vaccine Delivery Systems

  2014cited by this paper
• Translating chitosan to clinical delivery of nucleic acid-based drugs

  2014cited by this paper
• Mannosylation of Virus-Like Particles Enhances Internalization by Antigen Presenting Cells

  2014cited by this paper
• Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites

  2014cited by this paper
• Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults.

  2014cited by this paper
• Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering.

  2014influential reference
• Vaccines for the 21st century

  2014cited by this paper
• Vaccines and melanoma.

  2014cited by this paper
• Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

  2014cited by this paper
• Recent progress in adjuvant discovery for peptide-based subunit vaccines

  2014cited by this paper
• T Cell Responses to Viral Infections – Opportunities for Peptide Vaccination

  2014cited by this paper
• Breast cancer immunotherapy: monoclonal antibodies and peptide-based vaccines

  2014cited by this paper
• Engaging adaptive immunity with biomaterials.

  2014influential reference
• Surface-modified P(HEMA-co-MAA) nanogel carriers for oral vaccine delivery: design, characterization, and in vitro targeting evaluation.

  2014cited by this paper
• Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines

  2014cited by this paper
• Evaluation of safety and efficacy as an adjuvant for the chitosan-based vaccine delivery vehicle ViscoGel in a single-blind randomised Phase I/IIa clinical trial.

  2014cited by this paper
• Development of stabilized glucomannosylated chitosan nanoparticles using tandem crosslinking method for oral vaccine delivery.

  2014cited by this paper
• Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases.

  2014cited by this paper
• Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles

  2013influential reference
• Messenger RNA‐based vaccines: progress, challenges, applications

  2013cited by this paper
• Enhanced protection against pulmonary mycobacterial challenge by chitosan‐formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma‐interferon+ T cell responses

  2013cited by this paper
• Vaccine delivery carriers: insights and future perspectives.

  2013cited by this paper
• Enhanced Immune Response and Protective Effects of Nano-chitosan-based DNA Vaccine Encoding T Cell Epitopes of Esat-6 and FL against Mycobacterium Tuberculosis Infection

  2013influential reference
• Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.

  2013cited by this paper
• Molecular delivery of plasmids for genetic vaccination.

  2013cited by this paper
• Rapid Vaccination Using an Acetalated Dextran Microparticulate Subunit Vaccine Confers Protection Against Triplicate Challenge by Bacillus Anthracis

  2013cited by this paper
• Peptides for immunological purposes: design, strategies and applications

  2013influential reference
• Converging toward a common speech code: imitative and perceptuo-motor recalibration processes in speech production

  2013cited by this paper
• A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach

  2013cited by this paper
• Binding of Soluble Yeast β-Glucan to Human Neutrophils and Monocytes is Complement-Dependent

  2013cited by this paper
• Desirable attributes of vaccines for deployment in low-resource settings.

  2013cited by this paper
• Polysaccharide-based nucleic acid nanoformulations.

  2013influential reference
• Designing tomorrow's vaccines.

  2013cited by this paper
• Targeting Antigens to Dendritic Cell Receptors for Vaccine Development

  2013influential reference
• A Trifunctional Dextran-Based Nanovaccine Targets and Activates Murine Dendritic Cells, and Induces Potent Cellular and Humoral Immune Responses In Vivo

  2013cited by this paper
• Chitosan Nanoparticle Encapsulated Hemagglutinin-Split Influenza Virus Mucosal Vaccine

  2013influential reference
• Enhanced Nasal Mucosal Delivery and Immunogenicity of Anti-Caries DNA Vaccine through Incorporation of Anionic Liposomes in Chitosan/DNA Complexes

  2013cited by this paper
• Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.

  2013cited by this paper
• Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.

  2013cited by this paper
• Efficient delivery of the toll-like receptor agonists polyinosinic:polycytidylic acid and CpG to macrophages by acetalated dextran microparticles.

  2013cited by this paper
• Recombinant therapeutic protein vaccines.

  2013cited by this paper
• Enhanced Immunogenicity of a Tricomponent Mannan Tetanus Toxoid Conjugate Vaccine Targeted to Dendritic Cells via Dectin-1 by Incorporating β-Glucan

  2013influential reference
• Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.

  2013cited by this paper
• Reverse vaccinology in the 21st century: improvements over the original design

  2013cited by this paper
• The big picture on nanomedicine: the state of investigational and approved nanomedicine products.

  2013cited by this paper
• Working together: interactions between vaccine antigens and adjuvants

  2013cited by this paper
• Preliminary studies on the development of IgA-loaded chitosan–dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens

  2013cited by this paper
• Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review

  2012cited by this paper
• Intranasal immunisation of mice against Streptococcus equi using positively charged nanoparticulate carrier systems.

  2012influential reference
• Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.

  2012cited by this paper
• Cationization of Ganoderma lucidum polysaccharides in concentrated alkaline solutions as gene carriers

  2012cited by this paper
• Nanovaccines : nanocarriers for antigen delivery.

  2012cited by this paper
• PLGA-based nanoparticles: an overview of biomedical applications.

  2012cited by this paper
• Dextran Sodium Sulfate (DSS) Induces Colitis in Mice by Forming Nano-Lipocomplexes with Medium-Chain-Length Fatty Acids in the Colon

  2012cited by this paper
• Biodegradable Particles as Vaccine Delivery Systems: Size Matters

  2012cited by this paper
• Chitosan-based drug nanocarriers: where do we stand?

  2012cited by this paper
• Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.

  2012cited by this paper
• Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles.

  2012influential reference
• Oral Vaccination Based on DNA-Chitosan Nanoparticles against Schistosoma mansoni Infection

  2012cited by this paper
• Toll-like receptor-7 agonist decoration enhances the adjuvanticity of chitosan-DNA nanoparticles.

  2012cited by this paper
• Towards tailored vaccine delivery: needs, challenges and perspectives.

  2012cited by this paper
• Targeting tumor antigens to dendritic cells using particulate carriers.

  2012cited by this paper
• Dectin-1 targeting delivery of TNF-α antisense ODNs complexed with β-1,3-glucan protects mice from LPS-induced hepatitis.

  2011cited by this paper
• Chemistry, physico-chemistry and applications linked to biological activities of β-glucans.

  2011cited by this paper
• Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles

  2011cited by this paper
• Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents.

  2011cited by this paper
• Peptide-based subunit nanovaccines.

  2011influential reference
• Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial.

  2011cited by this paper
• Particulate vaccines: on the quest for optimal delivery and immune response.

  2011cited by this paper
• Norovirus vaccine against experimental human Norwalk Virus illness.

  2011cited by this paper
• Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.

  2011cited by this paper
• Carbohydrate-based immune adjuvants

  2011influential reference
• Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.

  2011cited by this paper
• TLR-based immune adjuvants.

  2011cited by this paper
• Defined particle ligands trigger specific defense mechanisms of macrophages

  2011cited by this paper
• Immunostimulatory activity of polysaccharide-poly(I:C) nanoparticles.

  2011cited by this paper
• Activation of Antigen-Specific T Cell-Responses by Mannan-Decorated PLGA Nanoparticles

  2011cited by this paper
• Nanomedicine(s) under the microscope.

  2011cited by this paper
• Vaccines for the twenty-first century society

  2011cited by this paper
• Processing and Scale-up of Polymeric Nanoparticles

  2011cited by this paper
• Nanoparticles and the immune system.

  2010cited by this paper
• Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?

  2010influential reference
• Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

  2010cited by this paper
• Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses

  2010cited by this paper
• Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.

  2010cited by this paper
• Chitosan-based nanoparticles for improving immunization against hepatitis B infection.

  2010cited by this paper
• Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

  2010cited by this paper
• From single-dose vaccine delivery systems to nanovaccines

  2010cited by this paper
• Polymeric particles in vaccine delivery.

  2010cited by this paper
• Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems.

  2010influential reference
• Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.

  2010influential reference
• Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.

  2010influential reference
• Nanotechnology solutions for mucosal immunization.

  2010cited by this paper
• Polysaccharide‐modified synthetic polymeric biomaterials

  2010cited by this paper
• β‐glucan recognition by the innate immune system

  2009influential reference
• Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch.

  2009cited by this paper

• Stable Liposome–Hydrogel composites as multistage drug delivery systems

  2026cites this paper
• Development of nanoparticle-based Toll-like receptor agonists for respiratory immunotherapy

  2026cites this paper
• DEVELOPMENT OF ANTI INFLAMMATORY OIL MICROSPHERE AND EVALUATING THE ACTIVITY IN VITRO AND IN VIVO

  2026cites this paper
• Nanovehicles for delivery of antigens and adjuvants as cancer nanovaccines.

  2025cites this paper
• Current Status and Potential of Immune Adjuvants in Mycotoxin Immune Enhancement: Mechanisms, Innovations, and Applications.

  2025cites this paper
• Immune Modulation with Oral DNA/RNA Nanoparticles

  2025cites this paper
• Revolutionizing mRNA Vaccines Through Innovative Formulation and Delivery Strategies

  2025cites this paper
• LBP-CD155 Liposome Nanovaccine Efficiently Resist Colorectal Cancer and Enhance ICB Therapy

  2025cites this paper
• Polysaccharide Adjuvants as Innate Immune Trainers: Bridging Pattern Recognition Receptor (PRR) Activation and Metabolic Reprogramming for Synthetic Vaccine Design

  2025cites this paper
• Next-Generation Vaccine Platforms: Integrating Synthetic Biology, Nanotechnology, and Systems Immunology for Improved Immunogenicity

  2025cites this paper
• Maltodextrin-Nanoparticles as a Delivery System for Nasal Vaccines: A Review Article

  2024cites this paper
• Recent Advances in Multifaceted Drug Delivery Using Natural Polysaccharides and Polyacrylamide-Based Nanomaterials in Nanoformulation.

  2024cites this paper
• Natural polysaccharides: The potential biomacromolecules for treating diabetes and its complications via AGEs-RAGE-oxidative stress axis.

  2024cites this paper
• Aminated nano-crystalline cellulose decorated binary Ag-ZnO nanocomposite particles with a comparative study of antimicrobial activity and cell viability

  2024cites this paper
• Exploration of chitosan and its modified derivatives as vaccine adjuvant: A Review

  2024cites this paper
• Engineered inulin-based hybrid biomaterials for augmented immunomodulatory responses.

  2024cites this paper
• The emerging applications of niosome as a nanotechnology-based approach in vaccine delivery

  2024cites this paper
• Live attenuated Mycobacterium bovis strains combined with the encapsulated H65 antigen as a vaccine strategy against bovine tuberculosis in a mouse model.

  2024cites this paper
• SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice

  2023cites this paper
• Importance of adjuvant selection in tuberculosis vaccine development: Exploring basic mechanisms and clinical implications

  2023cites this paper
• A Glance on Nanovaccine: A Potential Approach for Disease Prevention.

  2023cites this paper
• Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens

  2023cites this paper
• Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing.

  2023cites this paper
• Current status of nano‐vaccinology in veterinary medicine science

  2023cites this paper
• Multifunctional cellulose-based biomaterials for dental applications: A sustainable approach to oral health and regeneration

  2023cites this paper
• Polysaccharides—Naturally Occurring Immune Modulators

  2023cites this paper
• Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases

  2023cites this paper
• Fungal β-Glucan-Based Nanotherapeutics: From Fabrication to Application

  2023cites this paper
• Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines.

  2023cites this paper
• Inulin acetate as a novel recombinant subunit vaccine carrier for immunization of tilapia against tilapia lake virus

  2023cites this paper
• Natural Polysaccharide-Based Nanodrug Delivery Systems for Treatment of Diabetes

  2022cites this paper
• Long-Term Vaccine Delivery and Immunological Responses Using Biodegradable Polymer-Based Carriers.

  2022cites this paper
• Chitosan-based nanoparticles in drug delivery

  2022cites this paper
• Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19

  2022cites this paper
• Nonordered dendritic mesoporous silica nanoparticles as promising platforms for advanced methods of diagnosis and therapies

  2022cites this paper
• Bio inspired materials for nonviral vaccine delivery

  2021cites this paper
• Exopolysaccharides in Drug Delivery Systems

  2021cites this paper
• Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response

  2021cites this paper
• Enhancement of Antioxidant and Hydrophobic Properties of Alginate via Aromatic Derivatization: Preparation, Characterization, and Evaluation

  2021cites this paper
• Nanotechnologies for the delivery of biologicals: historical perspective and current landscape.

  2021cites this paper
• Carbohydrate-containing nanoparticles as vaccine adjuvants

  2021cites this paper
• Adjuvanticity of β -Glucan for Vaccine Against Trichinella spiralis

  2021cites this paper
• Carboxymethyl-β-glucan/chitosan nanoparticles: new thermostable and efficient carriers for antigen delivery

  2021cites this paper
• Strategies to load therapeutics into polysaccharide-based nanogels with a focus on microfluidics: A review.

  2021cites this paper
• Recent advances on chitosan as an adjuvant for vaccine delivery.

  2021cites this paper
• The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination

  2021cites this paper
• Polysaccharide peptide conjugates: Chemistry, properties and applications.

  2021cites this paper
• Biopolymer‐based Carriers for DNA Vaccine Design

  2020cites this paper
• β‐glucan as a new tool in vaccine development

  2020cites this paper
• Technological challenges in the preclinical development of an HIV nanovaccine candidate

  2020cites this paper
• Unveiling the pitfalls of the protein corona of polymeric drug nanocarriers

  2020cites this paper
• Insight into Nanomedicinal Approaches to Combat Viral Zoonoses.

  2020cites this paper
• Carbohydrate Conjugates in Vaccine Developments

  2020cites this paper
• Epiphanies of well-known and newly discovered macromolecular carbohydrates - A review.

  2020cites this paper
• Prevention of influenza virus infection and transmission by intranasal administration of a porous maltodextrin nanoparticle-formulated vaccine.

  2020cites this paper
• Lentinan improved the efficacy of vaccine against Trichinella spiralis in an NLRP3 dependent manner

  2020cites this paper
• Self‐Assembled Nanoparticles: Exciting Platforms for Vaccination

  2020cites this paper
• Biomimetic nanomedicine toward personalized disease theranostics

  2020cites this paper
• Engineering polymeric nanocapsules for an efficient drainage and biodistribution in the lymphatic system

  2019cites this paper
• Biodegradable polymers for modern vaccine development

  2019cites this paper
• Polydopamine as the Antigen Delivery Nanocarrier for Enhanced Immune Response in Tumor Immunotherapy.

  2019cites this paper
• Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity.

  2019cites this paper
• Cationic polysaccharide spermine-pullulan drives tumor associated macrophage towards M1 phenotype to inhibit tumor progression.

  2019cites this paper
• Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen

  2019cites this paper
• Polysaccharide PCP-I isolated from Poria cocos enhances the immunogenicity and protection of an anthrax protective antigen-based vaccine

  2019cites this paper
• Design of polymeric nanocapsules to improve their lympho-targeting capacity.

  2019cites this paper
• First-In-Human Trials of GamTBvac, a Recombinant Subunit Tuberculosis Vaccine Candidate: Safety and Immunogenicity Assessment

  2019cites this paper
• Plasmid-DNA lipid and polymeric nanovaccines: a new strategic in vaccines development

  2019cites this paper
• Natural Polysaccharide Nanomaterials: An Overview of Their Immunological Properties

  2019cites this paper
• Designing self-assembled peptide nanovaccine against Streptococcus pneumoniae: An in silico strategy

  2019cites this paper
• An overview of nanogel-based vaccines

  2019cites this paper
• Pharmaceutical applications of natural polysaccharides

  2019cites this paper
• Immunostimulant and biocompatible gold and silver nanoparticles synthesized using the Ulva intestinalis L. aqueous extract.

  2019cites this paper
• Engineering, on‐demand manufacturing, and scaling‐up of polymeric nanocapsules

  2018cites this paper
• Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.

  2018cites this paper
• Dendritic Cell-Targeted Nanovaccine Delivery System Prepared with an Immune-Active Polymer.

  2018cites this paper
• Engineering detoxified pneumococcal pneumolysin derivative ΔA146PLY for self-biomineralization of calcium phosphate: Assessment of their protective efficacy in murine infection models.

  2018cites this paper
• Polysaccharide Submicrocarrier for Improved Pulmonary Delivery of Poorly Soluble Anti-infective Ciprofloxacin: Preparation, Characterization, and Influence of Size on Cellular Uptake.

  2018cites this paper
• Protamine Nanocapsules for the Development of Thermostable Adjuvanted Nanovaccines.

  2018cites this paper
• Microneedle arrays for vaccine delivery: the possibilities, challenges and use of nanoparticles as a combinatorial approach for enhanced vaccine immunogenicity

  2018cites this paper
• Chitosan:&bgr;‐glucan particles as a new adjuvant for the hepatitis B antigen

  2018cites this paper
• Nanoparticle vaccines against viral infections

  2018cites this paper
• Potential applications and human biosafety of nanomaterials used in nanomedicine

  2018cites this paper
• Evaluation of Mucosal Vaccines against Pneumococcal and Meningococcal Diseases

  2017cites this paper
• Modulating the immune system through nanotechnology.

  2017cites this paper
• Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models

  2017cites this paper
• Bioengineering towards self-assembly of particulate vaccines.

  2017cites this paper
• Recent developments in nanocarrier-aided mucosal vaccination.

  2017cites this paper
• Promising Effects of Beta-Glucans on Metabolism and on the Immune Responses: Review Article

  2017cites this paper
• Synthetic parasites: a successful mucosal nanoparticle vaccine against Toxoplasma congenital infection in mice.

  2017cites this paper
• Harnessing self-assembled peptide nanoparticles in epitope vaccine design

  2017cites this paper
• Near-infrared light-responsive nanotherapeutic agents: application in medical oncology

  2017cites this paper
• Nanovaccines for oral delivery-formulation strategies and challenges

  2017cites this paper
• PLY for self-biomineralization of calcium phosphate : Assessment of their protective ef fi cacy in murine infection models

  2017cites this paper
• Recent advances in vaccine delivery.

  2016cites this paper
• EVALUATION OF ALPHA-D-GLUCAN NANOPARTICLE AS A VACCINE ADJUVANT

  2016cites this paper
• Clay-lipid nanohybrids: towards influenza vaccines and beyond

  2016cites this paper
• Mesoporous silica nanoparticles as a potential vaccine adjuvant against Schistosoma mansoni

  2016cites this paper
• Advanced Application of Natural Polysaccharides

  2016cites this paper
• Rutin-loaded chitosan microspheres: Characterization and evaluation of the anti-inflammatory activity.

  2016cites this paper